Cleveland Clinic and IBM officially unveiled the first deployment of an onsite private sector IBM-managed quantum computer in the United States. The Quantum System One installed at Cleveland Clinic will be the first quantum computer in the world to be uniquely dedicated to healthcare research to help the clinic accelerate biomedical discoveries.
"This is a pivotal milestone in our innovative partnership with IBM, as we explore new ways to apply the power of quantum computing to healthcare," said Tom Mihaljevic, Cleveland Clinic CEO and President. "This technology holds tremendous promise in revolutionizing healthcare and expediting progress toward new care, cures, and solutions for patients. Quantum and other advanced computing technologies will help researchers tackle historic scientific bottlenecks and potentially find new treatments for patients with diseases like cancer, Alzheimer's, and diabetes.
"With the unveiling of IBM Quantum System One at Cleveland Clinic, their team of world-class researchers can now explore and uncover new scientific advancements in biomedical research," said Arvind Krishna, IBM Chairman, and CEO. "By combining the power of quantum computing, artificial intelligence, and other next-generation technologies with Cleveland Clinic's world-renowned leadership in healthcare and life sciences, we hope to ignite a new era of accelerated discovery.
In addition to quantum computing, the Cleveland Clinic-IBM Discovery Accelerator draws upon a variety of the latest advancements in computing technologies, including high-performance computing via the hybrid cloud and artificial intelligence. Researchers from both organizations are collaborating closely on a robust portfolio of projects with these advanced technologies to generate and analyze massive amounts of data to enhance research. The Accelerator has generated multiple projects that leverage the latest in quantum computing, AI, and hybrid cloud to help expedite discoveries in biomedical research. These include the development of quantum computing pipelines to screen and optimize drugs targeted to specific proteins, improvement of a quantum-enhanced prediction model for cardiovascular risk following non-cardiac surgery, and application of artificial intelligence to search genome sequencing findings and large drug-target databases to find effective, existing drugs that could help patients with Alzheimer's and other diseases.
The Discovery Accelerator also serves as the technology foundation for Cleveland Clinic's Global Center for Pathogen & Human Health Research, part of the Cleveland Innovation District. The center, supported by a $500 million investment from the State of Ohio, Jobs Ohio, and Cleveland Clinic, brings together a team focused on studying, preparing, and protecting against emerging pathogens and virus-related diseases. Through the Discovery Accelerator, researchers are leveraging advanced computational technology to expedite critical research into treatments and vaccines. A significant part of the collaboration is a focus on educating the workforce of the future and creating jobs to grow the economy. An innovative educational curriculum is being designed for participants from high school to the professional level, offering training and certification programs in data science, machine learning, and quantum computing to build the skilled workforce needed for cutting-edge computational research of the future.
With its Vivalytic analysis platform, Bosch has set itself the goal of making fast and highly precise diagnostics accessible at the point of care – and aims to use molecular diagnostics to become a leading provider in the market by 2030.
The certified electronic mail service PEC (Posta Elettronica Certificata), introduced in Italy in 2005, continues to generate significant sustainability, economic and environmental benefits.
Spam and scam calls have become a global plague, affecting millions of users and generating significant economic losses.
